Systemic Effects of Epidural Methylprednisolone Injection on Glucose Tolerance in Diabetic Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01420497 |
Recruitment Status :
Completed
First Posted : August 19, 2011
Last Update Posted : August 19, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diabetes Healthy | Drug: intra-articular infiltration Drug: epidural infiltration | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 25 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Study Start Date : | August 2008 |
Actual Primary Completion Date : | September 2008 |
Actual Study Completion Date : | June 2010 |
Arm | Intervention/treatment |
---|---|
Active Comparator: methylprednisolone,infiltration |
Drug: intra-articular infiltration
intra articular infiltration |
Active Comparator: epidural injection |
Drug: epidural infiltration
epidural infiltration |
- glycemic values, [ Time Frame: day 0 to day 15 ]
- urinary excretion rate [ Time Frame: day 0 to day 15 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- diabetes stable for more than ten days
- no contraindication for steroids
- lumbar stenosis
- articular pain
Exclusion Criteria:
- unstable diabetes
- renal insufficiency

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01420497
Switzerland | |
CHUV | |
Lausanne, VD, Switzerland, 1001 |
Responsible Party: | zufferey Pascal, md, Centre Hospitalier Universitaire Vaudois |
ClinicalTrials.gov Identifier: | NCT01420497 |
Other Study ID Numbers: |
gylperi |
First Posted: | August 19, 2011 Key Record Dates |
Last Update Posted: | August 19, 2011 |
Last Verified: | August 2011 |
methylprednisolone intra articular infiltration glycemia epidural infiltration diabetes |